Vericel to Present at 2016 Cell & Gene Meeting on the Mesa
Sep 26, 2016 12:01 pm UTC| Business
CAMBRIDGE, Mass., Sept. 26, 2016 -- Vericel Corporation (Nasdaq:VCEL), a leading developer of autologous cellular therapies for the treatment of severe diseases and conditions, today announced that Nick Colangelo,...
Sep 26, 2016 12:01 pm UTC| Business
TEL AVIV, Israel, Sept. 26, 2016 -- Bioblast Pharma Ltd. (Nasdaq:ORPN), a clinical-stage, orphan disease-focused biotechnology company, today announced that Zohar Argov, MD, Special Medical Advisor to the Executive...
Sep 26, 2016 12:01 pm UTC| Business
TEL AVIV, Israel, Sept. 26, 2016 -- Bioblast Pharma Ltd. (Nasdaq:ORPN), a clinical-stage, orphan disease-focused biotechnology company, today announced that Zohar Argov, MD, Special Medical Advisor to the Executive...
Mateon Announces Collaboration with US Oncology Research to Participate in Phase 2/3 FOCUS Study
Sep 26, 2016 12:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Sept. 26, 2016 -- Mateon Therapeutics, Inc. (Nasdaq:MATN), a biopharmaceutical company developing vascular disrupting agents (VDAs) for the treatment of orphan oncology indications, today...
Cartesian Announces Listing Transfer to the Nasdaq Capital Market
Sep 26, 2016 12:00 pm UTC| Business
OVERLAND PARK, Kan., Sept. 26, 2016 -- Cartesian™ (NASDAQ:CRTN), a leading provider of consulting services and managed solutions to the global telecom, media and technology industries, has received approval from the...
Hurco Technology Empowers Manufacturers at the International Manufacturing Technology Show
Sep 26, 2016 12:00 pm UTC| Business
INDIANAPOLIS, Sept. 26, 2016 -- Hurco Companies, Inc. (Nasdaq:HURC), showcased manufacturing technologies that solve the problems manufacturers confront each day at the International Manufacturing Technology Show (IMTS)...
Sep 26, 2016 12:00 pm UTC| Business
SAN DIEGO, Sept. 26, 2016 -- Fate Therapeutics, Inc. (NASDAQ:FATE), a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, announced today that...